Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 18, 2015

Total Value: $208M (100.0% shares, 0.0% debt)

Holdings (59)

GILD GILEAD SCIENCES INC 5.7%
Value $11.78M Shares 125,000 Share Price $94.26 * Est. Cost/Share $71.85 Unrealized @ Report Date 0.0%
ZBH ZIMMER HLDGS INC 4.7%
Value $9.777M Shares 86,200 Share Price $113.42 * Est. Cost/Share $92.36 Unrealized @ Report Date +4.2%
SYK STRYKER CORP 4.5%
Value $9.433M Shares 100,000 Share Price $94.33 * Est. Cost/Share $77.85 Unrealized @ Report Date 0.0%
— ISIS PHARMACEUTICALS INC 4.4%
Value $9.261M Shares 150,000 Share Price $61.74 Est. Cost/Share — Unrealized @ Report Date —
— AVALANCHE BIOTECHNOLOGIES IN 3.2%
Value $6.75M Shares 125,000 Share Price $54.00 Est. Cost/Share $46.08 Unrealized @ Report Date —
— WRIGHT MED GROUP INC 3.0%
Value $6.314M Shares 235,000 Share Price $26.87 Est. Cost/Share $26.87 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 2.9%
Value $6.127M Shares 65,000 Share Price $94.26 * Est. Cost/Share $71.85 Unrealized @ Report Date 0.0%
PBYI PUMA BIOTECHNOLOGY INC 2.7%
Value $5.678M Shares 30,000 Share Price $189.27 * Est. Cost/Share $214.23 Unrealized @ Report Date +3.6%
— FLAMEL TECHNOLOGIES SA 2.7%
Value $5.567M Shares 325,000 Share Price $17.13 Est. Cost/Share $17.13 Unrealized @ Report Date —
— CEPHEID 2.6%
Value $5.414M Shares 100,000 Share Price $54.14 Est. Cost/Share $54.14 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 2.6%
Value $5.335M Shares 55,000 Share Price $97.00 * Est. Cost/Share $71.51 Unrealized @ Report Date +29.6%
— LA JOLLA PHARMACEUTICAL CO 2.5%
Value $5.278M Shares 286,053 Share Price $18.45 Est. Cost/Share $18.45 Unrealized @ Report Date —
— DEPOMED INC 2.3%
Value $4.833M Shares 300,000 Share Price $16.11 Est. Cost/Share $14.77 Unrealized @ Report Date —
— DYAX CORP 2.2%
Value $4.57M Shares 325,000 Share Price $14.06 Est. Cost/Share $14.06 Unrealized @ Report Date —
— ACTAVIS PLC 2.2%
Value $4.505M Shares 17,500 Share Price $257.43 Est. Cost/Share $227.98 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 2.1%
Value $4.466M Shares 160,000 Share Price $27.91 Est. Cost/Share $22.63 Unrealized @ Report Date —
— NEVRO CORP 2.1%
Value $4.447M Shares 115,000 Share Price $38.67 Est. Cost/Share $38.67 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 2.1%
Value $4.4M Shares 85,000 Share Price $51.76 * Est. Cost/Share $36.53 Unrealized @ Report Date +20.5%
— PORTOLA PHARMACEUTICALS INC 2.0%
Value $4.248M Shares 150,000 Share Price $28.32 Est. Cost/Share $25.99 Unrealized @ Report Date —
— NUVASIVE INC 2.0%
Value $4.244M Shares 90,000 Share Price $47.16 Est. Cost/Share $40.34 Unrealized @ Report Date —
— INSYS THERAPEUTICS INC NEW 2.0%
Value $4.216M Shares 100,000 Share Price $42.16 Est. Cost/Share $42.16 Unrealized @ Report Date —
— HORIZON PHARMA PLC 1.9%
Value $3.867M Shares 300,000 Share Price $12.89 Est. Cost/Share $12.28 Unrealized @ Report Date —
— AIR METHODS CORP 1.8%
Value $3.743M Shares 85,000 Share Price $44.04 Est. Cost/Share $44.04 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 1.7%
Value $3.616M Shares 40,000 Share Price $90.40 * Est. Cost/Share $83.16 Unrealized @ Report Date 0.0%
— KITE PHARMA INC 1.7%
Value $3.46M Shares 60,000 Share Price $57.67 Est. Cost/Share $57.67 Unrealized @ Report Date —
— SALIX PHARMACEUTICALS INC 1.7%
Value $3.448M Shares 30,000 Share Price $114.93 Est. Cost/Share $114.93 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 1.6%
Value $3.41M Shares 80,000 Share Price $42.63 Est. Cost/Share $42.63 Unrealized @ Report Date —
— ADVAXIS INC 1.6%
Value $3.389M Shares 423,100 Share Price $8.01 Est. Cost/Share $8.01 Unrealized @ Report Date —
UHS UNIVERSAL HLTH SVCS INC 1.6%
Value $3.338M Shares 30,000 Share Price $111.27 * Est. Cost/Share $100.30 Unrealized @ Report Date 0.0%
SYK STRYKER CORP 1.6%
Value $3.302M Shares 35,000 Share Price $94.34 * Est. Cost/Share $77.85 Unrealized @ Report Date 0.0%
— ISIS PHARMACEUTICALS INC 1.5%
Value $3.087M Shares 50,000 Share Price $61.74 Est. Cost/Share — Unrealized @ Report Date —
— OPHTHOTECH CORP 1.4%
Value $2.917M Shares 65,000 Share Price $44.88 Est. Cost/Share $44.88 Unrealized @ Report Date —
— QUIDEL CORP 1.4%
Value $2.892M Shares 100,000 Share Price $28.92 Est. Cost/Share $26.87 Unrealized @ Report Date —
— VALEANT PHARMACEUTICALS INTL 1.4%
Value $2.862M Shares 20,000 Share Price $143.10 Est. Cost/Share $131.20 Unrealized @ Report Date —
— THERAPEUTICSMD INC 1.4%
Value $2.834M Shares 636,800 Share Price $4.45 Est. Cost/Share $5.07 Unrealized @ Report Date —
— BLUEBIRD BIO INC 1.3%
Value $2.752M Shares 30,000 Share Price $91.73 Est. Cost/Share $35.89 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 1.2%
Value $2.496M Shares 300,000 Share Price $8.32 * Est. Cost/Share $6.86 Unrealized @ Report Date 0.0%
ARAY ACCURAY INC 1.1%
Value $2.265M Shares 300,000 Share Price $7.55 * Est. Cost/Share $7.05 Unrealized @ Report Date 0.0%
— DBV TECHNOLOGIES S A 1.0%
Value $2.17M Shares 80,000 Share Price $27.13 Est. Cost/Share $27.13 Unrealized @ Report Date —
ISRG INTUITIVE SURGICAL INC 1.0%
Value $2.116M Shares 4,000 Share Price $529.00 * Est. Cost/Share $49.65 Unrealized @ Report Date +12.2%
— BIODELIVERY SCIENCES INTL IN 1.0%
Value $2.104M Shares 175,000 Share Price $12.02 Est. Cost/Share $12.02 Unrealized @ Report Date —
— ARIAD PHARMACEUTICALS INC 1.0%
Value $2.061M Shares 300,000 Share Price $6.87 Est. Cost/Share $5.40 Unrealized @ Report Date —
ATRC ATRICURE INC 1.0%
Value $1.996M Shares 100,000 Share Price $19.96 * Est. Cost/Share $17.88 Unrealized @ Report Date -4.0%
— ACHILLION PHARMACEUTICALS IN 0.9%
Value $1.838M Shares 150,000 Share Price $12.25 Est. Cost/Share — Unrealized @ Report Date —
— IMMUNOGEN INC 0.9%
Value $1.83M Shares 300,000 Share Price $6.10 Est. Cost/Share $6.10 Unrealized @ Report Date —
— BELLICUM PHARMACEUTICALS INC 0.8%
Value $1.728M Shares 75,000 Share Price $23.04 Est. Cost/Share $23.04 Unrealized @ Report Date —
— RAPTOR PHARMACEUTICAL CORP 0.8%
Value $1.578M Shares 150,000 Share Price $10.52 Est. Cost/Share $10.52 Unrealized @ Report Date —
MMSI MERIT MED SYS INC 0.6%
Value $1.3M Shares 75,000 Share Price $17.33 * Est. Cost/Share $14.79 Unrealized @ Report Date 0.0%
— TANDEM DIABETES CARE INC 0.6%
Value $1.27M Shares 100,000 Share Price $12.70 Est. Cost/Share $13.42 Unrealized @ Report Date —
— NANOSTRING TECHNOLOGIES INC 0.6%
Value $1.254M Shares 90,000 Share Price $13.93 Est. Cost/Share $18.50 Unrealized @ Report Date —
SNN SMITH & NEPHEW PLC 0.5%
Value $1.102M Shares 30,000 Share Price $36.73 Est. Cost/Share $63.02 Unrealized @ Report Date —
— AUSPEX PHARMACEUTICALS INC 0.5%
Value $1.05M Shares 20,000 Share Price $52.50 Est. Cost/Share $52.50 Unrealized @ Report Date —
— WRIGHT MED GROUP INC 0.4%
Value $884K Shares 185,000 Share Price $4.78 Est. Cost/Share $2.33 Unrealized @ Report Date —
— OCERA THERAPEUTICS INC 0.4%
Value $796K Shares 125,000 Share Price $6.37 Est. Cost/Share $10.04 Unrealized @ Report Date —
— BIOLASE INC 0.4%
Value $789K Shares 300,000 Share Price $2.63 Est. Cost/Share $2.41 Unrealized @ Report Date —
— CELLADON CORP 0.4%
Value $781K Shares 40,000 Share Price $19.52 Est. Cost/Share $19.52 Unrealized @ Report Date —
CPRX CATALYST PHARM PARTNERS INC 0.4%
Value $743K Shares 250,000 Share Price $2.97 * Est. Cost/Share $2.74 Unrealized @ Report Date 0.0%
— ASSEMBLY BIOSCIENCES INC 0.2%
Value $511K Shares 65,000 Share Price $7.86 Est. Cost/Share $8.18 Unrealized @ Report Date —
GBIM GLOBEIMMUNE INC 0.1%
Value $178K Shares 23,500 Share Price $7.57 * Est. Cost/Share $6.97 Unrealized @ Report Date 0.0%